Steffen Pietzke - Net Worth and Insider Trading
Steffen Pietzke Net Worth
The estimated net worth of Steffen Pietzke is at least $237,817 dollars as of 2024-04-26. Steffen Pietzke is the CFO of Enovix Corp and owns about 22,000 shares of Enovix Corp (ENVX) stock worth over $137,280. Steffen Pietzke is the Controller and CAO of PDL BioPharma Inc and owns about 20,590 shares of PDL BioPharma Inc (PDLI) stock worth over $50,857. Steffen Pietzke is also the VP Fin & Chief Acct Officer of ALX Oncology Holdings Inc and owns about 3,000 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $49,680. Besides these, Steffen Pietzke also holds Tricida Inc (TCDAQ) . Details can be seen in Steffen Pietzke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steffen Pietzke has not made any transactions after 2021-08-12 and currently still holds the listed stock(s).
Transaction Summary of Steffen Pietzke
Steffen Pietzke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steffen Pietzke owns 4 companies in total, including ALX Oncology Holdings Inc (ALXO) , Tricida Inc (TCDAQ) , and PDL BioPharma Inc (PDLI) among others .
Click here to see the complete history of Steffen Pietzke’s form 4 insider trades.
Insider Ownership Summary of Steffen Pietzke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-07-21 | VP Fin & Chief Acct Officer |
| TCDAQ | Tricida Inc | 2018-07-02 | VP Fin & Chief Acct Officer |
| PDLI | PDL BioPharma Inc | 2017-12-15 | VP & Finance and CAO |
| ENVX | Enovix Corp | 2021-08-12 | Chief Financial Officer |
Steffen Pietzke Latest Holdings Summary
Steffen Pietzke currently owns a total of 4 stocks. Among these stocks, Steffen Pietzke owns 22,000 shares of Enovix Corp (ENVX) as of August 12, 2021, with a value of $137,280 and a weighting of 57.72%. Steffen Pietzke owns 20,590 shares of PDL BioPharma Inc (PDLI) as of December 7, 2015, with a value of $50,857 and a weighting of 21.39%. Steffen Pietzke also owns 3,000 shares of ALX Oncology Holdings Inc (ALXO) as of July 21, 2020, with a value of $49,680 and a weighting of 20.89%. The other 1 stocks Tricida Inc (TCDAQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Steffen Pietzke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENVX | Enovix Corp | 2021-08-12 | 22,000 | 6.24 | 137,280 |
| PDLI | PDL BioPharma Inc | 2015-12-07 | 20,590 | 2.47 | 50,857 |
| ALXO | ALX Oncology Holdings Inc | 2020-07-21 | 3,000 | 16.56 | 49,680 |
| TCDAQ | Tricida Inc | 2018-07-02 | 10,527 | 0.00 | 0 |
Holding Weightings of Steffen Pietzke
Steffen Pietzke Form 4 Trading Tracker
According to the SEC Form 4 filings, Steffen Pietzke has made a total of 1 transactions in Enovix Corp (ENVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enovix Corp is the acquisition of 20,000 shares on August 12, 2021, which cost Steffen Pietzke around $295,000.
According to the SEC Form 4 filings, Steffen Pietzke has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 20,590 shares on December 7, 2015, which cost Steffen Pietzke around $74,948.
According to the SEC Form 4 filings, Steffen Pietzke has made a total of 1 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 3,000 shares on July 21, 2020, which cost Steffen Pietzke around $57,000.
More details on Steffen Pietzke's insider transactions can be found in the Insider Trading History of Steffen Pietzke table.Insider Trading History of Steffen Pietzke
- 1
Steffen Pietzke Trading Performance
GuruFocus tracks the stock performance after each of Steffen Pietzke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steffen Pietzke is 41.28%. GuruFocus also compares Steffen Pietzke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steffen Pietzke within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steffen Pietzke's insider trading performs compared to the benchmark.
Performance of Steffen Pietzke
Average Return
33.38%
Outperforming Transactions
75%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.15 | 41.28 | 34.41 | 33.38 | -12.67 | -31.18 |
| Relative Return to S&P 500(%) | 5.78 | 37.77 | 31.64 | 21.71 | -20.33 | -43.42 |
Steffen Pietzke Ownership Network
Ownership Network List of Steffen Pietzke
Ownership Network Relation of Steffen Pietzke
Steffen Pietzke Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
Steffen Pietzke is the VP Fin & Chief Acct Officer of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include director & President and CEO Jaume Pons , director & 10 percent owner Jason Lettmann , and VP & Finance and CAO Shelly Pinto .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, Steffen Pietzke made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 73,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net purchase of 4,400 shares made by Jason Lettmann .
In summary, during the past 3 months, insiders sold 70,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 65,600 shares. During the past 18 months, 86,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 81,828 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
Steffen Pietzke Mailing Address
Above is the net worth, insider trading, and ownership report for Steffen Pietzke. You might contact Steffen Pietzke via mailing address: C/o Enovix Corporation, 3501 W. Warren Avenue, Fremont Ca 94538.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
